Rigel Pharmaceuticals (RIGL)
Commercializes specialty treatments for a blood disorder, a leukemia, and RET-fusion cancers in the US.
$48.14
After hours−0.66 (−1.36%)
At close$48.81(+3.64%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
$0.92
Revenue estimate
$80.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.80$0.63$3.28$1.46$1.14$0.44$0.88Pending
Estimate$0.30$0.14$1.97$0.93$1.33$0.74$0.09$0.92
Surprise+166.7%+350.0%+66.5%+57.0%−14.3%−40.5%+903.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$57.6M$53.3M$101.7M$69.5M$69.8M$58.8M$78.7MPending
Estimate$57.6M$48.3M$62.3M$68.4M$68.7M$62.4M$55.3M$80.1M
Surprise0.0%+10.4%+63.2%+1.5%+1.6%−5.7%+42.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $1.24 | — | — |
| Sep 2027 | $1.05 | — | — |
| Jun 2027 | $0.90 | — | — |
| Mar 2027 | $0.53 | — | — |
| Dec 2026 | $1.01 | — | — |
| Nov 2026 | $0.92 | — | — |
| Aug 2026 | $0.09 | $0.88 | +903.9% |
| May 2026 | $0.74 | $0.44 | −40.5% |
| Mar 2026 | $1.33 | $1.14 | −14.3% |
| Nov 2025 | $0.93 | $1.46 | +57.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $1.24 | — | — | $101.1M | — | — | — |
| Sep 2027 | $1.05 | — | — | $94.6M | — | — | — |
| Jun 2027 | $0.90 | — | — | $87.1M | — | — | — |
| Mar 2027 | $0.53 | — | — | $77.9M | — | — | — |
| Dec 2026 | $1.01 | — | — | $88.1M | — | — | — |
| Nov 3, 2026 | $0.92 | — | — | $80.1M | — | — | — |
| Aug 4, 2026 | $0.09 | $0.88 | +903.9% | $55.3M | $78.7M | +42.4% | +4.6% |
| May 5, 2026 | $0.74 | $0.44 | −40.5% | $62.4M | $58.8M | −5.7% | −5.1% |
| Mar 3, 2026 | $1.33 | $1.14 | −14.3% | $68.7M | $69.8M | +1.6% | −10.3% |
| Nov 4, 2025 | $0.93 | $1.46 | +57.0% | $68.4M | $69.5M | +1.5% | +33.4% |
| Aug 5, 2025 | |||||||
| May 6, 2025 | |||||||
| Mar 4, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Mar 5, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 1, 2023 | |||||||
| May 2, 2023 | |||||||
| Mar 7, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 2, 2022 | |||||||
| May 3, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Nov 2, 2021 | |||||||
| Aug 3, 2021 | |||||||
| May 5, 2021 | |||||||
| Mar 2, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 4, 2020 | |||||||
| May 5, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 5, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 1, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 1, 2017 | |||||||
| May 2, 2017 | |||||||
| Mar 7, 2017 | |||||||
| Nov 1, 2016 | |||||||
| Aug 2, 2016 | |||||||
| May 3, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 3, 2015 | |||||||
| Aug 4, 2015 |